Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells

NCT04751279 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04751279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04751279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression and Role of the JAK/STAT Pathway in Sarcoidosis Granuloma Cells
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Unknown status
Start date
March 9, 2021
Completion date
January 2, 2024
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

jak-stat pathway deregulation, sarcoidosis